cyclocreatine has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
cyclocreatine: structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matthews, RT | 1 |
| Ferrante, RJ | 1 |
| Klivenyi, P | 1 |
| Yang, L | 1 |
| Klein, AM | 1 |
| Mueller, G | 1 |
| Kaddurah-Daouk, R | 1 |
| Beal, MF | 1 |
1 other study available for cyclocreatine and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Creatine and cyclocreatine attenuate MPTP neurotoxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Administration, Oral; Ani | 1999 |